Holderfield, Matthew <br/><br/>
Vemurafenib cooperates with HPV to promote initiation of cutaneous tumors.  [electronic resource] 

 -  Cancer research  Apr 2014 
 - 2238-45 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1538-7445 
<br/><br/><label>Standard No.: </label>10.1158/0008-5472.CAN-13-1065-T  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Carcinoma, Squamous Cell--chemically induced<br/>Cell Line, Tumor<br/>Early Detection of Cancer<br/>Genotype<br/>Human papillomavirus 16--genetics<br/>Humans<br/>Indoles--administration & dosage<br/>Keratin-14--genetics<br/>MAP Kinase Signaling System--drug effects<br/>Mice<br/>Mice, Transgenic<br/>Promoter Regions, Genetic<br/>Skin Neoplasms--chemically induced<br/>Sulfonamides--administration & dosage<br/>Vemurafenib